Amalaki (Emblica).
One of the three fruits in Triphala, highest natural vitamin C
Reviewed March 2026
- Category
- Herb
- Also filed under
- Vitamin CAntioxidantCholesterol
What Amalaki (Emblica) is, and what it does.
- Does it work
- Suits people who want a tannin-rich fruit behind their daily antioxidant and digestive routine, and anyone already using triphala. It's a food form botanical rather than an isolated nutrient.
- How much to take
- Start with 250 to 500mg a day of extract, or about a teaspoon of the dried fruit powder. That band is where the fruit's tannins do their everyday work.
- Time to feel it
- Plan on four to eight weeks. Digestive regularity is the one thing some people notice inside the first week or two.
- The first dose
- Day one is mostly the taste, which is sharply sour. Some people notice a gentle nudge toward regularity, while the tannin chemistry works quietly.
- With regular use
- Most effects take 2-8 weeks. Be patient.
- How well tolerated
- Generally well tolerated. Check with your doctor if on medications.
- How it feels
- Sharply sour, close to puckering, if you take the powder straight. Past the taste it's quiet, with easier regularity the one thing people tend to report over the first weeks.
- The overlooked benefit
- How well its ellagitannins convert into urolithins depends on your own gut bacteria, so two people on the same dose end up with different metabolites circulating.
250 to 500mg a day is where Amalaki (Emblica) works.
Source: Kapoor et al., 2009; Ayurvedic pharmacopoeia
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Amalaki (Emblica) has emerging evidence. Based on 138+ studies.
- antioxidant capacity in laboratory assaysIn vitro study
- blood lipids already in the normal rangeRandomised trial
- digestive regularity as a triphala componentRandomised trial
- urolithin production by colonic bacteriaNarrative review
- vitamin C content of the fruitNarrative review
Questions people ask about Amalaki (Emblica).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Amla is ascorbate-dense, and ascorbate at the membrane surface donates an electron to the tocopheroxyl radical, returning vitamin E to its active form. This regeneration cycle is textbook antioxidant biochemistry.
Ascorbate reduces ferric iron to the ferrous form and keeps it soluble at intestinal pH, which is the step that governs non-heme iron uptake. Amla's tannin fraction pulls mildly in the other direction, so the net effect depends on the extract.
The hydrolysable tannins that dominate amla, emblicanin A and B and related gallo-ellagitannins, bind divalent metal ions in the gut lumen. Taken in the same dose window this lowers the fraction of zinc available for uptake.
Ascorbate and glutathione sit in the same redox couple, where glutathione reduces dehydroascorbate back to ascorbate and ascorbate spares glutathione consumption. Amla's ascorbate and polyphenol load feeds into that cycle.
Amla is one of the three fruits that make up triphala, so combining them raises the amla-derived tannin and ascorbate load in the same formula. Total gallotannin content is the figure to track, not the number of entries.
Amla polyphenols and curcuminoids are paired throughout Ayurvedic practice, and ascorbate helps hold curcumin in its reduced form against oxidative degradation in the gut. The two polyphenol classes feed the same Nrf2-linked antioxidant response.
Pippali piperine slows intestinal glucuronidation and P-glycoprotein efflux, the main routes clearing amla's polyphenols before they reach circulation. This is the classical trikatu logic applied to a fruit extract.
Standardised piperine reduces phase two conjugation in the gut wall, so more of the ellagitannin-derived metabolites survive first pass. It is the same mechanism as pippali in a characterised form.
Amla is the base of chyawanprash and ashwagandha the classical tonic root placed with it, one contributing polyphenol and ascorbate load, the other withanolides acting on the stress-response axis. The pairing is compositional and the chemistry does not overlap.
Guduchi adds immunomodulatory arabinogalactan polysaccharides that amla does not supply, while amla contributes the antioxidant and ascorbate fraction. Traditional rasayana blends combine them for that reason.
Amla fruit contains ascorbate, though much of the antioxidant capacity attributed to it in assays comes from hydrolysable tannins rather than from ascorbate itself. Added ascorbate raises the measurable vitamin C in a formula in a way the fruit alone does not reliably do. The two sit in the same redox cycle with tocopherol. Label vitamin C figures for whole amla extracts should be read as assay-dependent.
Lipoic acid regenerates ascorbate and glutathione, and amla polyphenols act as direct electron donors in the same network. Antioxidant capacity is measured as a marker, not as a health outcome. The pairing has laboratory grounding and no combination trial. Read it as network overlap.
Glutathione synthesis is limited by cysteine availability, and N-acetylcysteine supplies it. Polyphenol quinone metabolites are conjugated to glutathione during phase II handling. The relationship is substrate supply for a detoxification pathway, which is established biochemistry. It is not evidence of a combined clinical effect.
Glutathione peroxidases are selenium-dependent and handle hydrogen peroxide and lipid hydroperoxides. Plant polyphenols act on the same oxidative burden by a non-enzymatic route. Adequate selenium is a precondition for the enzymatic arm. This is cofactor physiology, not a measured pairing.
Gallotannins and ellagitannins bind divalent transition metals including copper, forming complexes that are poorly absorbed. Taken in the same window, a tannin-rich fruit extract lowers the fraction of a copper dose that gets in. Spacing the two by a couple of hours is the usual handling. The same chemistry underlies the well-known polyphenol effect on plant-form iron.
Polyphenol-rich preparations reduce the absorbed fraction of several divalent minerals taken at the same time. Calcium is affected less than iron but the chemistry is the same class. Dosing the mineral away from the extract sidesteps it. The point is timing, not incompatibility.
Ellagitannins are hydrolysed to ellagic acid and then converted by colonic bacteria into urolithins, and people differ substantially in which urolithins they produce. That conversion capacity depends on gut microbial composition rather than on the dose taken. This is why the same extract behaves differently between individuals. The relationship is a metabolic dependency, established in the polyphenol literature.
Much of what reaches circulation after an ellagitannin-rich fruit is urolithin, not the parent tannin. Taking urolithin A directly bypasses the microbial step that many people convert poorly. The two are therefore related as precursor and metabolite rather than as an additive stack. Nothing about that relationship predicts the size of any effect.
Catechins and hydrolysable tannins both act as electron donors and both engage phase II conjugation on the way out. Antioxidant formulas combine them routinely. Total polyphenol load also raises the shared mineral-binding effect, which is the trade-off worth flagging. No combination trial addresses the pair.
Quercetin and amla polyphenols are both glucuronidated and sulfated during absorption, drawing on the same conjugating capacity. Co-dosing can shift the free fraction of either. Formulas combine them for antioxidant marker effects. Confidence stays moderate because the human data are on markers.
Ayurvedic rasayana preparations pair amalaki with bacopa in classical formulas with long use history. Neither has a mechanism that predicts the other. There is no combination trial. The grounding is use tradition, which is why the confidence sits at the bottom band.
Ginger appears alongside amalaki in many traditional digestive and rasayana preparations. The pairing is documented by use rather than by trial. Ginger also stimulates gastric secretion, which changes the environment a tannin-rich extract meets. Read it as a traditional pairing.
Nothing specific on file for Amalaki (Emblica). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Amalaki (Emblica) actually does.
The fruit is loaded with a family of plant tannins built around gallic and ellagic acid.
Hydrolysable tannins act as direct electron donors in antioxidant assays, which is why amla extracts score high on ORAC and similar in vitro measures. Those are laboratory measurements and not outcomes in a person.
Ellagitannins are hydrolysed to ellagic acid and then converted by colonic bacteria into urolithins, and urolithin production varies widely between individuals.
Tannins grab minerals in the gut, so timing them apart matters.
Where Amalaki (Emblica) comes from.
The small sour fruit is deseeded and dried, then either ground into powder or soaked to pull out its tannins, which are concentrated and dried into an extract.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Small green-yellow fruits are harvested from trees across South and Southeast Asia, mostly from cultivated orchards and some wild collection. Fruit is picked at maturity in the cooler months.
Fruits are deseeded and dried, traditionally in the sun and industrially in low-temperature dryers. Drying temperature is what determines how much of the heat-sensitive ascorbate survives.
Dried fruit is extracted with water or an ethanol-water mix depending on which constituents are wanted, then the extract is concentrated under vacuum.
Concentrated extract is filtered and spray dried onto a carrier, commonly maltodextrin, to produce a free-flowing powder.
Extracts are standardised by HPLC or spectrophotometry against total tannins, gallic acid or emblicanins. Vitamin C figures, where quoted, depend on the assay and on how much of the reading is tannin interference.
Material ships as loose powder, encapsulated extract, or juice. Whole powder and standardised extract are different materials and should not be compared by weight.
Drying temperature and carrier content in spray-dried extracts are rarely disclosed, and both bear directly on the vitamin C figure a label quotes.
Getting Amalaki (Emblica) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A review of Triphala, the traditional blend in which amalaki is one of the three fruits, describes antioxidant and digestive-regularity effects reported across small human and laboratory studies, with the human work still early and not isolating amalaki on its own.Systematic review. Bairwa et al., 2025 (International journal of physiology, pathophysiology and pharmacology). PMID 40401115 ↗
- A geroprotection protocol including amalaki reported changes in heart rate variability, oxidative enzyme activity and gene expression readouts; all of these are markers rather than clinical outcomes, and amalaki was one component of a multi-ingredient protocol.Open-label trial. Lewis et al., 2026 (Journal of Ayurveda and Integrative Medicine). PMID 42172813 ↗
These are the studies our verdict leans on, chosen from the 46 we read for Amalaki (Emblica). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.